The scientist’s investigation covers issues in Human leukocyte antigen, Epitope, Genetics, Virology and Immunology. William H. Hildebrand has researched Human leukocyte antigen in several fields, including Transplantation and Peptide. His studies deal with areas such as T cell, MHC class I, CD8, Molecular biology and HLA-A as well as Epitope.
His work is dedicated to discovering how CD8, Peptide binding are connected with Computational biology and other disciplines. He is involved in the study of Genetics that focuses on Allele in particular. His studies in Virology integrate themes in fields like Cytotoxic T cell, CTL* and Peptide sequence.
His scientific interests lie mostly in Human leukocyte antigen, Epitope, Immunology, Virology and Molecular biology. His Human leukocyte antigen study integrates concerns from other disciplines, such as Antibody, Major histocompatibility complex and Peptide. His biological study spans a wide range of topics, including Cell, Antigen presentation and Cell biology.
His Epitope study combines topics in areas such as T cell, T-cell receptor, Peptide sequence, CTL* and Monoclonal antibody. The Immunity and Serology research William H. Hildebrand does as part of his general Immunology study is frequently linked to other disciplines of science, such as Class, therefore creating a link between diverse domains of science. The concepts of his Virology study are interwoven with issues in Cytotoxic T cell and CD8.
Human leukocyte antigen, Immunology, Major histocompatibility complex, T cell and Peptide are his primary areas of study. The various areas that William H. Hildebrand examines in his Human leukocyte antigen study include Epitope, Molecular biology, Monoclonal antibody and T-cell receptor. The study incorporates disciplines such as Transplantation and Virology in addition to Immunology.
His research in Major histocompatibility complex intersects with topics in Autoimmunity, Antigen presentation and Cell biology. The various areas that William H. Hildebrand examines in his T cell study include CD8 and Allergy. His work carried out in the field of Peptide brings together such families of science as Antigen processing, MHC class I, Proteomics and HLA-A.
William H. Hildebrand mostly deals with Human leukocyte antigen, Major histocompatibility complex, Immunology, Peptide and MHC class I. The study incorporates disciplines such as Epitope, Cytotoxic T cell and Plasma protein binding in addition to Human leukocyte antigen. His study in Allele extends to Epitope with its themes.
His Major histocompatibility complex study incorporates themes from Autoimmunity, Antigen presentation and Cell biology. The concepts of his Immunology study are interwoven with issues in Mesenchymal stem cell and Virology. His study in Peptide is interdisciplinary in nature, drawing from both Protein structure and Amino acid.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome.
Neal Flomenberg;Lee Ann Baxter-Lowe;Dennis Confer;Marcelo Fernandez-Vina.
A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
Beatriz M. Carreno;Vincent Magrini;Michelle Becker-Hapak;Saghar Kaabinejadian.
T cells from patients with Parkinson’s disease recognize α-synuclein peptides
David Sulzer;Roy N. Alcalay;Francesca Garretti;Lucien Cote.
Relative Dominance of Gag p24-Specific Cytotoxic T Lymphocytes Is Associated with Human Immunodeficiency Virus Control
Rosario Zuñiga;Aldo Lucchetti;Patricia Galvan;Shyla Sanchez.
Journal of Virology (2006)
Unusual HLA-B alleles in two tribes of Brazilian Indians
M P Belich;J A Madrigal;W H Hildebrand;J Zemmour.
Recognition of lyso-phospholipids by human natural killer T lymphocytes.
Lisa M. Fox;Daryl G. Cox;Jennifer L. Lockridge;Xiaohua Wang.
PLOS Biology (2009)
Abacavir induces loading of novel self-peptides into HLA-B*57:01: an autoimmune model for HLA-associated drug hypersensitivity
Michael A. Norcross;Shen Luo;Li Lu;Michael T. Boyne.
Determination of Cellular Lipids Bound to Human CD1d Molecules
Daryl Cox;Daryl Cox;Lisa Fox;Runying Tian;Wilfried Bardet.
PLOS ONE (2009)
Definition of the viral targets of protective HIV-1-specific T cell responses.
Beatriz Mothe;Anuska Llano;F. Javier Ibarrondo;Marcus Daniels.
Journal of Translational Medicine (2011)
Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B*08 and HLA-B*2705, bind peptides with sequence similarity.
John T. Loffredo;John Sidney;Alex T. Bean;Dominic R. Beal.
Journal of Immunology (2009)
(Impact Factor: 2.211)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: